Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseases.
Toyama K, Yaguchi M, Mizoguchi H, Masuda M, Urabe A, Ikeda Y, Aoki I, Shinbo T, Togawa A, Hirashima K, Miura Y, Hirose S, Tsuruoka N, Omine M, Kamakura M, Saito T, Arimori S, Aoki N, Kuraishi Y, Hirai H, Asano S, Mori M, Shirai T, Muto Y, Takaku F, et al. Toyama K, et al. Among authors: tsuruoka n. Kansenshogaku Zasshi. 1996 Dec;70(12):1242-53. doi: 10.11150/kansenshogakuzasshi1970.70.1242. Kansenshogaku Zasshi. 1996. PMID: 9011117 Clinical Trial.
Clinical-study of multiple-myeloma in the elderly.
Tomiyama J, Kudo H, Nakamura N, Murai Y, Tsunadori S, Muto Y, Urabe A, Mori M, Tsuruoka N, Shirai T, Kawado M, Adachi Y, Shirakura T, Yamaguchi H, Katsunuma H. Tomiyama J, et al. Among authors: tsuruoka n. Oncol Rep. 1995 Jul;2(4):669-73. doi: 10.3892/or.2.4.669. Oncol Rep. 1995. PMID: 21597796
Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R. Takeshita A, et al. Among authors: tsuruoka n. Int J Hematol. 2000 Feb;71(2):136-43. Int J Hematol. 2000. PMID: 10745623 Clinical Trial.
Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
Fujita M, Shimazu M, Nagashima K, Suzuki M, Tauchi I, Sakuma M, Yamamoto S, Shozu M, Hanaoka H, Tsuruoka N, Kasai T, Hata A. Fujita M, et al. Among authors: tsuruoka n. BMJ Open. 2022 Feb 3;12(2):e049803. doi: 10.1136/bmjopen-2021-049803. BMJ Open. 2022. PMID: 35115348 Free PMC article.
Effective collaboration between IL-4 and IL-21 on B cell activation.
Saito T, Kitayama D, Sakamoto A, Tsuruoka N, Arima M, Hatano M, Miyazaki M, Tokuhisa T. Saito T, et al. Among authors: tsuruoka n. Immunobiology. 2008;213(7):545-55. doi: 10.1016/j.imbio.2008.01.006. Epub 2008 Feb 20. Immunobiology. 2008. PMID: 18656702
Bcl6 is a transcriptional repressor for the IL-18 gene.
Takeda N, Arima M, Tsuruoka N, Okada S, Hatano M, Sakamoto A, Kohno Y, Tokuhisa T. Takeda N, et al. Among authors: tsuruoka n. J Immunol. 2003 Jul 1;171(1):426-31. doi: 10.4049/jimmunol.171.1.426. J Immunol. 2003. PMID: 12817026
314 results